Linked Data API

Show Search Form

Search Results

860725
registered interest false more like this
date less than 2018-03-12more like thismore than 2018-03-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care remove filter
hansard heading Lumacaftor/ivacaftor more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what progress has been made on negotiations between NHS England and Vertex Pharmaceuticals on access to the drug Orkambi for people with cystic fibrosis. more like this
tabling member constituency Thornbury and Yate remove filter
tabling member printed
Luke Hall more like this
uin 132082 remove filter
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-20more like thismore than 2018-03-20
answer text <p>NHS England is currently in discussion with Vertex about its range of drugs for treating cystic fibrosis, including the drug Orkambi. NHS England will continue to support discussions with pharmaceutical companies that aim to provide clinically effective medicines to patients at a level that is cost-effective, in line with standard National Institute for Health and Care Excellence practice for assessing new drugs before they are introduced into the National Health Service.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-03-20T16:40:41.203Zmore like thismore than 2018-03-20T16:40:41.203Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4450
label Biography information for Luke Hall more like this